$3.95
0.19[5.05%]
At close: Apr 25
$3.95
0[0.00%]
PreMarket: 5:34PM EDT
Caribou Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Caribou Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | CRBU | Q1 | -$0.46 | -$0.40 | — | — | $3.50M | $2.90M | — | — | Get Alert |
03/11/2024 | PM | CRBU | Q4 | -$0.44 | -$0.37 | -$0.39 | -5.41% | $3.69M | $4.61M | $3.56M | -22.82% | Get Alert |
11/07/2023 | PM | CRBU | Q3 | -$0.44 | -$0.42 | -$0.12 | 71.43% | $3.30M | $3.15M | $23.66M | 651.17% | Get Alert |
08/08/2023 | PM | CRBU | Q2 | -$0.44 | -$0.49 | -$0.48 | 2.04% | $4.19M | $3.07M | $3.75M | 22.31% | Get Alert |
05/09/2023 | PM | CRBU | Q1 | -$0.32 | -$0.49 | -$0.46 | 6.12% | $2.66M | $3.15M | $3.50M | 11.17% | Get Alert |
03/09/2023 | PM | CRBU | Q4 | -$0.31 | -$0.46 | -$0.44 | 4.35% | $2.56M | $3.07M | $3.69M | 20.26% | Get Alert |
11/08/2022 | PM | CRBU | Q3 | -$0.46 | -$0.48 | -$0.44 | 8.33% | $3.98M | $3.70M | $3.30M | -10.73% | Get Alert |
08/09/2022 | PM | CRBU | Q2 | -$1.39 | -$0.36 | -$0.44 | -22.22% | $1.48M | $2.86M | $4.19M | 46.57% | Get Alert |
05/09/2022 | PM | CRBU | Q1 | -$1.39 | -$0.35 | -$0.32 | 8.57% | $1.59M | $3.20M | $2.66M | -16.75% | Get Alert |
03/21/2022 | PM | CRBU | Q4 | -$1.68 | -$0.36 | -$0.31 | 13.89% | $984.00K | $4.18M | $2.56M | -38.78% | Get Alert |
11/09/2021 | PM | CRBU | Q3 | — | -$0.12 | -$0.46 | -283.33% | — | $16.50M | $3.98M | -75.90% | Get Alert |
09/02/2021 | PM | CRBU | Q2 | — | — | -$1.39 | — | — | — | $1.48M | — | Get Alert |
Caribou Biosciences (CRBU) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 11, 2024 for Q4.
The Actual EPS was $-0.39, which missed the estimate of $-0.37.
The Actual Revenue was $3.6M, which missed the estimate of $4.6M.
Browse earnings estimates, EPS, and revenue on all stocks.